Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies .
Valora Therapeutics has raised $30.0M in total funding. The most recent round was Seed. The last funding was announced in November 2024.
Valora Therapeutics's investors include Correlation Ventures, Alexandria Venture Investments, Avalon BioVentures, TigerGene, Bregua.
Valora Therapeutics is headquartered in La Jolla, United States.
Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies .
Valora Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Valora Therapeutics — Funding & Investors." VCBacked, November 20, 2024, https://www.vcbacked.co/company/valora-therapeutics. Accessed July 19, 2026.
VCBacked. (2024). Valora Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/valora-therapeutics
{{cite web |title=Valora Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/valora-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated